Ball Titus B. reported option exercise involving 8,827 derivative units of BeOne Medicines Ltd. at $0.00 for $0 on Nov 6, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Principal Accounting Officer
Principal Accounting Officer
Filed Nov 10, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
8,827Share Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
6,513Direct
Trade date
Nov 6, 2026Option exercise
Filed
Nov 10, 2026, 4:59 PM ET4-day reporting delay
Accession
0001675628-26-000005Code M · Transaction 397274
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 6, 2026Option exercise880$207.55$182,644Trade 397269
Nov 6, 2026Option exercise679$159.03$107,981.37Trade 397270
Nov 6, 2026Option exercise11,440$0.00$0Trade 397273
Nov 6, 2026Sell1,533——Trade 397271
Nov 6, 2026Sell26——Trade 397272
6 transaction rows in this filing. Joint filers share the same rows.

ONC price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ONC · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 17, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −14%1w ago −13%1d ago −8.7%
Returns since7d30d90d180d1y

Footnotes in full

F1: Each American Depositary Share represents 13 Ordinary Shares. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $405.25 to $406.15, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. F3: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F4: These securities vest over a four-year period as follows: 25% on August 31, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. F5: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.